Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Purified Vero Rabies Vaccine (VRVg)
Purified Vero Rabies Vaccine · 1 trial · 1 indication
Rabies virus neutralizing antibody titer will be determined by the rapid fluorescent focus inhibition test (RFFIT)
| Arm | Type | Description |
|---|---|---|
| Purified Vero Rabies Vaccine Group | EXPERIMENTAL | Participants will receive the Purified Vero Rabies Vaccine (VRVg) |
| Imovax® Rabies Vaccine Group | EXPERIMENTAL | Participants will receive the Imovax® Rabies vaccine |
| Name | Type | Description |
|---|---|---|
| Purified Vero Rabies Vaccine (VRVg) | BIOLOGICAL | 0.5 mL, Intramuscular |
| Imovax® Rabies: inactivated rabies vaccine | BIOLOGICAL | 1.0 mL, Intramuscular |
Inclusion Criteria: * Aged 18 to \< 65 years on the day of inclusion * Informed consent form has been signed and dated - Able to attend all scheduled visits and comply with all trial procedures. Exclusion Criteria: * Subject is pregnant, or lactating, or of childbearing potential (to be considere...
Purified Vero Rabies Vaccine is an investigational vaccine developed by Sanofi for the prevention of rabies. It is designed to be given as a simulated rabies post-exposure regimen. The vaccine is in Phase 2 clinical development and has been studied in healthy adult volunteers.
Purified Vero Rabies Vaccine is being developed for rabies, an infectious disease. It is intended for use in a rabies post-exposure regimen, meaning it is evaluated as a preventive treatment after potential exposure to the rabies virus. It is not yet approved and remains investigational.
Sanofi develops Purified Vero Rabies Vaccine. Sanofi trades on the New York Stock Exchange under the ticker SNY. The company is the sponsor of the clinical program evaluating this vaccine candidate for rabies prevention.
Purified Vero Rabies Vaccine is in Phase 2 clinical development. It is an investigational vaccine and is not FDA approved. The Phase 2 trial has been completed, and no active trials are currently listed for this vaccine candidate.
Purified Vero Rabies Vaccine has been studied in one completed Phase 2 trial, NCT01877395, titled Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen. The trial enrolled 342 participants in the United States and was controlled and randomized.
Yes, Purified Vero Rabies Vaccine is also known as Purified Vero Rabies Vaccine (VRVg). VRVg is an abbreviation used for the same Sanofi vaccine candidate being studied for rabies prevention in a simulated post-exposure regimen.